MedWatch

WS Audiology and GN settle false advertising case in US

Hearing aid firms WSA and GN Hearing-owned Lively have entered settlements with the Attorney General Connecticut Office. The firms had marketed products as “FDA-approved” when they were in fact only registered. ”An oversight,” a WSA representative calls it.

Photo: WS Audiology / PR

Hearing aid manufacturers WS Audiology and GN Hearing have been reprimanded by Connecticut Attorney General William Tong for having falsely marketed certain products in the US.

The case has ended in separate settlements with the Connecticut Office of the Attorney General, under which four companies will collectively pay USD 40,000 to the state and have agreed to cease the false marketing, a press release from the office, which industry media The Hearing Review first discovered, has announced.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Rumored GN purchase unlikely but not impossible, say analysts

A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.

New CFO wants to shake things up at WSA

A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.

Further reading

Related articles

Latest news

See all jobs